This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

The Night Watch: Idec Pharma Heads Lower

The extra session was a little on the slow side, but enough companies had news after the close to impact their stock prices.

Idec Pharmaceuticals (IDPH) was in the cross hairs after the company said it would halt clinical trials of an experimental drug because of safety concerns. Idec was falling 7.5% to $35.48 on Instinet after the close.

The top volume mover was Nortel (NT), which was flat with the 4 p.m. EDT close at $1.79. The telecom equipment provider said it brought in $1.475 billion with a recent financing deal.

On the whole, volume was somewhat light. In the first hour and 15 minutes of extended action, about 2.3 million shares changed hands among the 20 most active stocks on the Instinet platform.

Lucent (LU) and Intel (INTC - Get Report) were unchanged. Cisco (CSCO - Get Report) was down 0.8%, and WorldCom (WCOM) was off 0.6%.

Tyco (TYC) climbed 13% in regular trading but slipped 0.9% to $11.30 in extended activity.

Comcast (CMCSK) closed at a 52-week low, but ticked up 0.3% to $24.30 after the bell. The Nasdaq 100 Unit Trust (QQQ - Get Report) was inching ahead 0.2%, while Sun (SUNW) and Microsoft (MSFT - Get Report) were slightly lower.

The biggest loser was Numerical Technologies (NMTC), which plunged 31% to $4.26. The company, a designer of products for integrated circuit makers, lowered its guidance for the second quarter and full year, sparking the selloff.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
CSCO $27.13 0.00%
INTC $32.00 0.00%
MSFT $40.97 0.00%
QQQ $105.52 0.00%
AAPL $123.25 0.00%


DOW 17,712.66 +34.43 0.19%
S&P 500 2,061.02 +4.87 0.24%
NASDAQ 4,891.2190 +27.8570 0.57%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs